Dongwoo Khang Selected Research

Dongwoo Khang Research Topics

Disease

19	Inflammation (Inflammations) 03/2024 - 01/2013
14	Neoplasms (Cancer) 07/2023 - 07/2011
10	Anaphylaxis (Anaphylactic Shock) 01/2023 - 01/2015
7	Atopic Dermatitis (Atopic Eczema) 01/2022 - 05/2013
5	Hypothermia 01/2019 - 01/2015
4	Hypersensitivity (Allergy) 08/2020 - 01/2017
4	Asthma (Bronchial Asthma) 06/2020 - 01/2017
3	Arthritis (Polyarthritis) 12/2023 - 03/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 12/2021
2	Lung Neoplasms (Lung Cancer) 01/2023 - 11/2017
2	Rheumatoid Arthritis 01/2023 - 01/2017
2	Infections 11/2022 - 08/2010
2	Brain Neoplasms (Brain Tumor) 01/2019 - 09/2012
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2017 - 03/2016
2	Cushing Syndrome 01/2017 - 03/2016
2	Hyperglycemia 01/2017 - 03/2016
2	Joint Diseases (Joint Disease) 01/2017 - 03/2016
2	Osteoporosis 01/2017 - 03/2016
1	Experimental Arthritis 01/2023
1	Leukemia 01/2023
1	COVID-19 11/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Melanoma (Melanoma, Malignant) 06/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Glaucoma 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Allergic Rhinitis 01/2019
1	Acute Lung Injury 11/2017
1	Lung Diseases (Lung Disease) 11/2017
1	Brain Edema (Cerebral Edema) 01/2017
1	Multiple Sclerosis 01/2017
1	Osteoarthritis 01/2017
1	Rhinitis 01/2017

Drug/Important Bio-Agent (IBA)

11	Immunoglobulin E (IgE)IBA 01/2023 - 01/2015
8	Carbon Nanotubes (Carbon Nanotube)IBA 01/2023 - 01/2012
7	OvalbuminIBA 01/2023 - 01/2015
4	Histamine (Histamine Dihydrochloride)FDA Link 08/2020 - 09/2015
3	GoldIBA 03/2024 - 11/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2023 - 10/2013
3	Immunoglobulins (Immunoglobulin)IBA 05/2021 - 01/2017
3	CarbonIBA 02/2018 - 07/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 03/2016
2	Imiquimod (Aldara)FDA LinkGeneric 03/2024 - 12/2021
2	Triamcinolone (Aristocort)FDA Link 12/2023 - 03/2016
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022 - 01/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 07/2011
2	Immunoglobulin G (IgG)IBA 05/2021 - 01/2017
2	FlavonoidsIBA 08/2020 - 12/2017
2	CytokinesIBA 08/2020 - 01/2016
2	CalciumIBA 11/2019 - 01/2016
2	Interleukin-4 (Interleukin 4)IBA 01/2019 - 09/2015
2	CaveolinsIBA 02/2018 - 01/2017
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2017 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2017 - 09/2012
2	4-hydroxyphenylethanolIBA 11/2017 - 01/2015
2	p-Methoxy-N-methylphenethylamineIBA 01/2017 - 01/2016
1	Interleukin-22 (IL-22)IBA 12/2023
1	poly(lactide) (polylactic acid)IBA 07/2023
1	Proteins (Proteins, Gene)FDA Link 07/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2023
1	NanovaccinesIBA 11/2022
1	Messenger RNA (mRNA)IBA 11/2022
1	VaccinesIBA 11/2022
1	COVID-19 VaccinesIBA 11/2022
1	Claudin-1IBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 12/2021
1	gomisin M2IBA 12/2021
1	Ursolic AcidIBA 10/2021
1	hispidulinIBA 05/2021
1	Dinitrochlorobenzene (DNCB)IBA 05/2021
1	ChemokinesIBA 01/2021
1	orientinIBA 08/2020
1	dabrafenibIBA 06/2020
1	Ophthalmic Solutions (Eye Drops)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Cetrimonium (CTAB)IBA 11/2019
1	Transient Receptor Potential ChannelsIBA 11/2019
1	IonsIBA 11/2019
1	Protons (Proton)IBA 11/2019
1	nothofaginIBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	Propolis (Bee Bread)IBA 12/2017
1	chrysinIBA 12/2017
1	LipopolysaccharidesIBA 11/2017
1	2-hydroxy-3-methoxybenzoic acidIBA 01/2017
1	perfluorooctanoic acidIBA 01/2017
1	M 92 (VA 2)IBA 01/2017
1	GlucocorticoidsIBA 01/2017

Therapy/Procedure

6	Oral Administration 12/2021 - 01/2015
5	Therapeutics 07/2023 - 01/2017
3	Photothermal Therapy 03/2024 - 01/2023
2	Lasers (Laser) 12/2023 - 01/2023
1	Immunotherapy 01/2020